Salt Lake City, UT – March 24, 2025 – J3 Bioscience, Inc., a commercialization stage startup medical device company focused on women’s health, today announced the appointment of John Fair as its new President and Chief Executive Officer, effective immediately. Founder and current CEO Tyler McCabe will transition to the role of Chief Operating Officer.
Mr. Fair, who has served on J3’s board of directors for the past year, brings deep experience and a strong track record in women’s health, including leadership in strategic planning and commercialization across the pharmaceutical, biotech, and medical device sectors. His background includes:
- More than 20 years of senior leadership in biopharma and medical devices
- Expertise in corporate and business development, brand strategy, and both provider- and consumer-facing commercialization
- A history of securing major partnerships in the women’s health space, including one of the largest deals in the reproductive health category with Bayer Healthcare
- Proven success in capital formation, with over $80M in institutional funding raised
- Extensive experience with innovative consumer brands
Most recently, Mr. Fair served as Chief Business Officer at a life sciences company developing next-generation pharmaceutical therapies and diagnostic solutions for serious women’s health conditions. Prior to that, he was Chief Business Development & Chief Commercial Officer at Daré Bioscience, where he led commercialization efforts across a portfolio of women’s health therapeutics and devices.
“John brings a powerful blend of strategic vision and industry expertise, making him the perfect leader to drive our goals and objectives during this next phase,” stated Dr. McCabe. “His proficiency in leveraging consumer insights, building strong brands, fostering growth, and securing critical strategic partnerships with category leaders aligns seamlessly with J3’s ambitions. I’ve personally known John and believe his talents are exactly what we need to add significant value to the company. I look forward to supporting him as we continue advancing our mission of successfully commercializing LivRing and expanding J3’s corporate outreach.”
“I’m excited to lead J3 Bioscience as we push the boundaries of what’s possible in women’s health,” said John Fair, President and CEO. “The company’s commitment to science-driven innovation aligns with my passion for advancing accessible, impactful healthcare. I look forward to partnering with this exceptional team to drive meaningful growth and bring forward new solutions that transform the lives of women.”
The board of directors unanimously approved Mr. Fair’s appointment, citing his leadership, strategic expertise, and track record in commercializing women’s health products as key factors in their decision.
About J3 Bioscience, Inc.
J3 Bioscience, Inc. is a women’s health medical device startup headquartered in Salt Lake City, Utah.
Media Contact:
R. Tyler McCabe, Chief Operating Officer, [email protected]